蛋白酶激活的诊疗一体化纳米药物用于子宫内膜异位症治疗
Protease‐Activated Theranostic Nanomedicine for Endometriosis Treatment
研究针对子宫内膜异位症病灶中MMP-9异常高表达,设计出MMP-9可切割肽功能化纳米颗粒,在酶激活后产生turn-on成像信号,并经体外与体内实验及抑制剂试验验证其MMP-9依赖性特异性。体内光声成像实现了病灶的精准定位与实时监测,离体近红外荧光成像结果与之相互印证。该纳米颗粒还作为letrozole(LTZ)载体,经MMP-9介导在病灶内选择性释药,在增强疗效的同时减轻全身副作用与毒性。
- 背景
- 子宫内膜异位症以子宫内膜组织异位生长为特征,伴随盆腔疼痛与不孕,现有诊疗手段有待改进。
- 做法
- 研究者在病灶中识别出基质金属蛋白酶-9(MMP-9)异常高表达,据此设计以MMP-9可切割肽修饰的纳米颗粒,酶激活后产生开启型成像信号,并作为来曲唑(LTZ)的载体。体外与体内实验连同抑制剂实验验证了颗粒对MMP-9活性的响应与特异性。
- 结论
- 体内光声成像实现了病灶的定位与实时监测,离体近红外荧光成像结果与之相互印证;纳米颗粒经MMP-9介导在病灶内选择性释放LTZ,提升了LTZ的疗效并降低其全身副作用与毒性。
- 意义
- 该平台将诊断与靶向治疗整合于一体,提示MMP-9响应型纳米治疗联合成像在妇科疾病精准医疗中的可能路径。摘要未给出样本量与效应量,相关定量证据需查阅原文。
原文摘要
出版方登记 · CrossrefEndometriosis is a chronic gynecological disorder characterized by ectopic growth of endometrial tissue and is associated with pelvic pain and infertility. Here, we identify aberrant matrix metalloproteinase‐9 (MMP‐9) overexpression in endometriotic lesions and develop a novel nanomedicine that integrates MMP‐9‐targeted therapy, ratiometric photoacoustic (PA) imaging, and controlled drug delivery to improve endometriosis diagnosis and treatment. We design MMP‐9‐cleavable peptide‐functionalized nanoparticles that produce turn‐on imaging signals upon enzymatic activation by MMP‐9, enabling sensitive and specific visualization of endometriotic lesions. Comprehensive in vitro and in vivo studies validate the responsiveness of the nanoparticles to MMP‐9 activity, with inhibitor assays confirming MMP‐9‐dependent specificity. In vivo PA imaging demonstrates precise localization and real‐time monitoring of endometriotic lesions, findings further corroborated by ex vivo tissue analyses using near‐infrared fluorescence imaging. Importantly, these peptide‐based nanoparticles serve as carriers for the targeted delivery of letrozole (LTZ), a potent therapeutic agent, allowing selective drug release via MMP‐9‐mediated enzymatic activity within endometriotic lesions. This targeted delivery enhanced the therapeutic efficacy of LTZ while minimizing its systemic side effects and toxicity. Collectively, our integrated theranostic nanoplatform enables simultaneous diagnosis and targeted therapy of endometriosis, highlighting the potential of MMP‐9‐responsive nanotherapeutics combined with advanced imaging for precision medicine in gynecological disorders.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
本页是 AI 精读,不转载论文原文;完整论文(含方法、图表与参考文献)见原文
来源:Advanced Functional Materials · doi.org